Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_assertion type Assertion NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_head.
- NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_assertion description "[In this pilot study, we utilized a retroviral vector expressing methylguanine DNA methyltransferase (MGMT) to transduce hematopoietic progenitors, which were subsequently used in the setting of alkylator therapy (procarbazine, CCNU, vincristine (PCV)) for poor prognosis brain tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_provenance.
- NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_assertion evidence source_evidence_literature NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_provenance.
- NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_assertion SIO_000772 16645619 NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_provenance.
- NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_assertion wasDerivedFrom befree-2016 NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_provenance.
- NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_assertion wasGeneratedBy ECO_0000203 NP547315.RAEHPtZO-2s72zDa5kRIexxGu3zJsgfhEzjS0YDJM4RRk130_provenance.